Teva
Pharmaceutical Industries Ltd.
  • Teva Worldwide
  • Stock
     
  • Contact Us
  • Hebrew

See Teva's sites around the world

Americas

  • Argentina
  • Brazil
  • Canada
  • Chile
  • Curacao
  • Mexico
  • Peru
  • Uruguay
  • USA and its Territories

EMIA-APAC

  • Australia
  • Belarus
  • China
  • India
  • Israel
  • Kazakhstan
  • Russia
  • Singapore
  • South Africa
  • Turkey
  • Ukraine
  • Uzbekistan

Japan & S. Korea

  • Japan
  • South Korea

Europe

  • Austria
  • Belgium
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania 
  • Macedonia
  • Monaco
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
See AllSee Less
Want to find out more about Teva's locations and phone numbers? Visit Teva Worldwide
Teva
  • About
    • About Lobby
    • Company Profile
    • Corporate Officers
    • Corporate Governance
    • Board of Directors
    • Our History
    Who We Are

    2016 Annual Report on Form 20-F

    Quality

    Quality

    Notice of Annual Meeting of Shareholders 2017 – Proxy Statement

    Notice of Annual Meeting of Shareholders 2017 – Proxy Statement

  • Products
    • Products Lobby
    • Specialty
    • Generic Products
    • Generic FAQ
    • Over the Counter (OTC)
    • API
    • Quality
    Central Nervous System (CNS)

    Central Nervous System (CNS)

    Respiratory

    Respiratory

  • Research
    • Research Lobby
    • Integrated R&D
    • Our Focus
    • Patient Promise
    • Pipeline
    National Network of Excellence

    National Network of Excellence

  • Responsibility
    • Responsibility Lobby
    • Position on Antimicrobial Resistance (AMR)
    • 2016 Social Impact Report
    • Previous CSR Reports
    Supplier Code of Conduct & Information for Our Suppliers

    Supplier Code of Conduct & Information for Our Suppliers

    Global Patient Organization and Advocacy Disclosure

    Global Patient Organization and Advocacy Disclosure

  • Media
    • Media Lobby
    • Latest News
    • Featured Stories
      Four New Independent Directors Join the Teva Board

      Four New Independent Directors Join the Teva Board

    • Investors
      • News
      • Webcasts and Presentations
      • Corporate Governance
      • Financial Information
      • Debt Information
      • Stock Information
      • Shareholder Information
      • Analysts Coverage/Consensus
      • Investor Kit
      • Contact Us
    • Careers
      • Dare to be different
      • Our Guiding Values
      • Leadership Development
      • Working at Teva
      Brand Manager

      Dare to be different

    • Follow Us:
    • Teva
    • Investor Relations
    • Recent Acquisitions

    Recent Acquisitions

    Go to Parent

    • News
    • Webcasts and Presentations
    • Corporate Governance
    • Financial Information
    • Debt Information
    • Stock Information
    • Shareholder Information
    • Analyst Coverage/Consensus
    • Investor Kit
    • Contact Us

    Tool Kit

    Print PagePrint Page
    E-mail PageE-mail Page
    RSS FeedsRSS Feeds
    E-mail AlertsE-mail Alerts
    IR ContactsIR Contacts
    ?FAQ
    • Taiyo Acquisition
    • Cephalon Acquisition
    • ratiopharm Acquisition

    Press Releases

    July 14, 2011
    Teva Completes Acquisition of Taiyo, The Third Largest Generics Company In Japan

    May 16, 2011
    Teva to Acquire Taiyo (English)
    Teva to Acquire Taiyo (Hebrew)


    Webcasts & Presentations

    May 16, 2011, 8:30 AM ET

    Investor Call to discuss the acquisition of Taiyo

    Presentation from Investor Call to Discuss the Acquisition of Taiyo



    Press Releases

    October 14, 2011

    Teva Completes Acquisition of Cephalon

    October 13, 2011

    Teva and Cephalon Receive European Commission Approval For Acquisition


    October 7, 2011

    U.S. Federal Trade Commission Clears Teva's Acquisition of Cephalon


    May 2, 2011

    Teva to Acquire Cephalon (English)

    Teva to Acquire Cephalon (Hebrew)


    Webcasts & Presentations

    May 2, 2011, 8:30 AM ET

    Investor Call to discuss the acquisition of Cephalon

    Presentation from Investor Call to Discuss the Acquisition of Cephalon


    Q&A for former Cephalon stockholders


    For Cephalon's press releases - click here

    For Cephalon's SEC filings - click here


    Press Releases


    August 10, 2010
    Teva Completes Acquisition of ratiopharm


    June 18, 2010
    Teva Announces Completion of $2.5 Billion of Senior Notes Offering Secures Financing for ratiopharm Acquisition


    June 15, 2010
    Teva Announces Pricing of $2.5 Billion of Senior Notes Secures Financing for ratiopharm Acquisition


    March 18, 2010
    Teva to Acquire ratiopharm (English)
    Teva to Acquire ratiopharm (Hebrew)


    Webcasts


    March 19, 2010 1:00 PM ET
    Investor Meeting

    • About
      • Company Profile
      • Corporate Officers
      • Corporate Governance
      • Board of Directors
      • Excellence
      • Our History
    • R&D
      • Integrated R&D
      • Our Focus
      • Partnerships
      • Patient Promise
      • Pipeline
      • Business Development
    • Products
      • Specialty
      • Generic Products
      • Generic FAQ
      • Over the Counter (OTC)
      • API
      • Quality
    • Responsibility
      • Teva Awards
      • Our Patients
      • Governance & Ethics
      • Our Employees
      • Environmental Responsibility
      • Our Communities
    • Media
      • Latest News
      • Featured Stories
      • Media Albums
      • Teva Fact Sheet
      • Teva Overview
    • Investors
      • News
      • News
      • Webcasts and Presentations
      • Corporate Governance
      • Financial Information
      • Stock Information
      • Shareholder Information
      • Analysts Coverage/Consensus
      • Investor Kit
      • Contact Us
    • Careers
      • All Jobs
      • Grow with the Best
      • Our Guiding Values
      • Leadership Development
      • European Leadership Programme
      • Our people
    Teva
    • Follow Teva:
    • Legal Notes
    • Sitemap
    • ©2018 TEVA Pharmaceutical LTD.